Three-fold overestimation of tumor mutation burden using 248 gene panel versus whole exome.

12117Background: Next generation sequencing (NGS) Gene panel testing is used to imputed tumor mutational burden (iTMB) and has shown rough correlation with TMB derived from whole exome sequencing (...